Impact of adjuvant trastuzumab-based chemotherapy in T1ab node-negative HER2 overexpressing breast carcinomas.
Jean-Sebastien Frenel
No relevant relationships to disclose
Manuel Jorge Rodrigues
No relevant relationships to disclose
Julien Peron
No relevant relationships to disclose
Vano Yann-Alexandre
No relevant relationships to disclose
Johanna Wassermann
No relevant relationships to disclose
Marc Debled
No relevant relationships to disclose
Francois Picaud
No relevant relationships to disclose
Laurence Albiges
No relevant relationships to disclose
Anne Vincent-Salomon
No relevant relationships to disclose
Paul H. Cottu
No relevant relationships to disclose